hr

Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Top
Topic: Endoscopy for Liver Cancer and Related Complications

A special issue of Hepatoma Research

ISSN 2454-2520 (Online), ISSN 2394-5079 (Print)

Submission deadline: 15 Mar 2023

Guest Editor(s)

  • Louis Ho Shing Lau, MB, ChB, FHKAM

    Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, China.

    Website | E-mail

  • Rashid N.S. Lui, MB, ChB, FRCP

    Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, China.

    Website | E-mail

Special Issue Introduction

Recent therapeutic advances have significantly improved the survival and quality of life for patients with liver cancer. As such, more patients having advanced disease may develop complications that require endoscopy such as variceal hemorrhage. Emerging treatment options delivered endoscopically, such as fecal microbiota transplantation for hepatic encephalopathy and beyond are also actively under research. Endoscopy will play an increasingly important role in the diagnosis, risk stratification, treatment and follow up of these patients. In this special issue, we explore advances in endoscopy and its interface with liver cancer and the potentially exciting developments that the future may hold.

Submission Deadline

15 Mar 2023

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://hrjournal.net/pages/view/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=hr&SpecialIssueId=hr220429
Submission Deadline: 15 Mar 2023
Contacts: Paula Dong, Assistant Editor, editor_Paula@hrjournal.net

Published Articles

This special issue is now open for submission.
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties